Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis
Open Access
- 4 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9), e73247
- https://doi.org/10.1371/journal.pone.0073247
Abstract
The number of steps taken per day (steps/day) provides a reliable and valid outcome of free-living walking behavior in persons with multiple sclerosis (MS). This study examined the clinical meaningfulness of steps/day using the minimal clinically important difference (MCID) value across stages representing the developing impact of MS. This study was a secondary analysis of de-identified data from 15 investigations totaling 786 persons with MS and 157 healthy controls. All participants provided demographic information and wore an accelerometer or pedometer during the waking hours of a 7-day period. Those with MS further provided real-life, health, and clinical information and completed the Multiple Sclerosis Walking Scale-12 (MSWS-12) and Patient Determined Disease Steps (PDDS) scale. MCID estimates were based on regression analyses and analysis of variance for between group differences. The mean MCID from self-report scales that capture subtle changes in ambulation (1-point change in PDSS scores and 10-point change in MSWS-12 scores) was 779 steps/day (14% of mean score for MS sample); the mean MCID for clinical/health outcomes (MS type, duration, weight status) was 1,455 steps/day (26% of mean score for MS sample); real-life anchors (unemployment, divorce, assistive device use) resulted in a mean MCID of 2,580 steps/day (45% of mean score for MS sample); and the MCID for the cumulative impact of MS (MS vs. control) was 2,747 steps/day (48% of mean score for MS sample). The change in motion sensor output of ∼800 steps/day appears to represent a lower-bound estimate of clinically meaningful change in free-living walking behavior in interventions of MS.Keywords
This publication has 18 references indexed in Scilit:
- Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosisBMC Neurology, 2013
- Increasing Physical Activity in Multiple Sclerosis Using a Behavioral InterventionBehavioral Medicine, 2011
- Ambulatory Activity in Individuals With Multiple SclerosisJournal of Neurologic Physical Therapy, 2011
- Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulsesMedical Science Monitor, 2011
- Possible clinical outcome measures for clinical trials in patients with multiple sclerosisTherapeutic Advances in Neurological Disorders, 2010
- Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measuresMultiple Sclerosis Journal, 2010
- Reliability of Scores from Physical Activity Monitors in Adults with Multiple SclerosisAdapted Physical Activity Quarterly, 2007
- Persistent pain and uncomfortable sensations in persons with multiple sclerosisPain, 2007
- Quantified measurement of activity provides insight into motor function and recovery in neurological diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Defining the clinical course of multiple sclerosisNeurology, 1996